International Journal of Biotechnology 9(3/4) 2007 is a special issue: Vaccines: all things considered.
Article titles:
* Preliminary evidence of efficacy from an open label trial of a therapeutic AIDS vaccine derived from the blood of HIV-positive donors
* Immunostimulants in the prevention of respiratory infections
* Safety and immunogenicity of bivalent inactivated vaccine against haemorrhagic fever with renal syndrome in a phase II trial on healthy Chinese volunteers
* Comparative effect of an immunomodulator Immunoxel (DzhereloT™) when used alone or in combination with antiretroviral therapy in drug-naive HIV-infected individuals
* Envelope-based HIV vaccine peptides as antigens in HIV-1 immunodiagnostics
* Developing Plasmodium falciparum malaria vaccines for populations living in areas with stable parasite transmission
* Anti-HIV and anti-inflammatory action of iodine-lithium-α-dextrin is accompanied by the improved quality of life in AIDS patients
* Preclinical and safety studies of V-1 Immunitor
* Possible role of molecular mimicry in pathogenesis of Ebola virus: implications for a rational vaccine design
* Mechanism of action and therapeutic efficacy of the biotechnology-derived immunostimulating extract OM-85 in respiratory tract infections
* HIV-1 subtype C vaccine: waiting in wings for the human trials
* Immunity development following oral vaccination against Actinobacillus pleuropneumoniae in a mouse model
* Regulation of cancer by therapeutic vaccination and dietary bio-modulation involving organ-specific mitochondria
No comments:
Post a Comment